Cargando…
miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
Autores principales: | Liu, Kai, Liu, Songyang, Zhang, Wei, Ji, Bai, Wang, Yingchao, Liu, Yahui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577794/ https://www.ncbi.nlm.nih.gov/pubmed/34726253 http://dx.doi.org/10.3892/ijo.2021.5280 |
Ejemplares similares
-
miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma
por: Liu, Yahui, et al.
Publicado: (2022) -
miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN
por: Liu, Kai, et al.
Publicado: (2022) -
miR-363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3
por: Ye, Junfeng, et al.
Publicado: (2021) -
Synergistic effects of co-expression plasmid-based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo
por: Liu, Songyang, et al.
Publicado: (2022) -
MicroRNA-744 inhibits migration and invasion of hepatocellular carcinoma cells by targeting SOX12
por: Zhang, Wei, et al.
Publicado: (2022)